These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Penicillamine in the treatment of scleroderma]. Kobíková M; Stáva Z Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784 [No Abstract] [Full Text] [Related]
10. [Marked proteinuria in the course of penicillamine treatment of progressive systemic sclerosis]. Filipecki S; Dabrowska B; Szczepański A; Glyda J Pol Tyg Lek; 1971 Nov; 26(46):1780-1. PubMed ID: 5131995 [No Abstract] [Full Text] [Related]
11. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)]. Helmke K; Velcovsky HG; Federlin K Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704 [TBL] [Abstract][Full Text] [Related]
12. [D-penicillamine therapy of chronic polyarthritis]. Günther R; Gabl F; Knapp E Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805 [No Abstract] [Full Text] [Related]
13. The toxicity of D-penicillamine in systemic sclerosis. Steen VD; Blair S; Medsger TA Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530 [TBL] [Abstract][Full Text] [Related]